Renal diseases as targets of gene therapy

Contributions to Nephrology

Volumn 159, Issue , 2008, Pages 1-12

  Phillips, B ^a   Giannoukakis, N ^a   Trucco, M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; GENE THERAPY; GENETICS; GRAFT SURVIVAL; HUMAN; KIDNEY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; METHODOLOGY; PATHOPHYSIOLOGY;

GENE THERAPY; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 48549105511     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000125552     Document Type: Review

References (30)

1. Gene therapy clincial trails worldwide. J Gene Med 2007.
2. Isaka Y: Gene therapy targeting kidney diseases: Routes and vehicles. Clin Exp Nephrol 2006;10:229-235.
3. Tomasoni S, Benigni A: Gene therapy: How to target the kidney. Promises and pitfalls. Curr Gene Ther 2004;4:115-122.
4. Hwang M, Kim HJ, Noh HJ, Chang YC, Chae YM, Kim KH, Jeon JP, Lee TS, Oh HK, Lee YS, Park KK: Tgf-beta1 sirna suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp Mol Pathol 2006;81:48-54.
5. Takabatake Y, Isaka Y, Mizui M, Kawachi H, Shimizu F, Ito T, Hori M, Imai E: Exploring rna interference as a therapeutic strategy for renal disease. Gene Ther 2005;12:965-973.
6. Tomita N, Kashihara N, Morishita R: Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease. Clin Exp Nephrol 2007;11:7-17.
7. Madry H, Reszka R, Bohlender J, Wagner J: Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo. J Mol Med (Berl, Germany) 2001;79:184-189.
8. Imai E, Takabatake Y, Mizui M, Isaka Y: Gene therapy in renal diseases. Kidney Int 2004;65:1551-1555.
9. Tsujie M, Isaka Y, Nakamura H, Kaneda Y, Imai E, Hori M: Prolonged transgene expression in glomeruli using an ebv replicon vector system combined with hvj liposomes. Kidney Int 2001;59:1390-1396.
10. Tsujie M, Isaka Y, Ando Y, Akagi Y, Kaneda Y, Ueda N, Imai E, Hori M: Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of japan liposome method. Kidney Int 2000;57:1973-1980.
11. Tsujie M, Isaka Y, Nakamura H, Imai E, Hori M: Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 2001;12:949-954.
12. Isaka Y, Nakamura H, Mizui M, Takabatake Y, Horio M, Kawachi H, Shimizu F, Imai E, Hori M: Dnazyme for tgf-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 2004;66:586-590.
13. Newman CM, Bettinger T: Gene therapy progress and prospects: Ultrasound for gene transfer. Gene Ther 2007;14:465-475.
14. Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, Tachibana K, Ogihara T, Morishita R: An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 2005;7:108-116.
15. Worgall S: A realistic chance for gene therapy in the near future. Pediatr Nephrol (Berl, Germany) 2005;20:118-124.
16. Choi YK, Kim YJ, Park HS, Choi K, Paik SG, Lee YI, Park JG: Suppression of glomerulosclerosis by adenovirus-mediated il-10 expression in the kidney. Gene Ther 2003;10:559-568.
17. Schulick AH, Vassalli G, Dunn PF, Dong G, Rade JJ, Zamarron C, Dichek DA: Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity. J Clin Invest 1997;99:209-219.
18. Kapturczak MH, Chen S, Agarwal A: Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney. Acta Biochim Pol 2005;52:293-299.
19. Gusella GL, Fedorova E, Hanss B, Marras D, Klotman ME, Klotman PE: Lentiviral gene transduction of kidney. Hum Gene Ther 2002;13:407-414.
20. Benigni A, Tomasoni S, Turka LA, Longaretti L, Zentilin L, Mister M, Pezzotta A, Azzollini N, Noris M, Conti S, Abbate M, Giacca M, Remuzzi G: Adeno-associated virus-mediated ctla4ig gene transfer protects mhc-mismatched renal allografts from chronic rejection. J Am Soc Nephrol 2006;17:1665-1672.
21. Azuma H, Tomita N, Kaneda Y, Koike H, Ogihara T, Katsuoka Y, Morishita R: Transfection of nfkappab-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003;10:415-425.
22. Sandovici M, Deelman LE, van Goor H, Helfrich W, de Zeeuw D, Henning RH: Adenovirus-mediated interleukin-13 gene therapy attenuates acute kidney allograft injury. J Gene Med 2007.
23. Gorczynski R, Bransom J, Cattral M, Huang X, Lei J, Min W, Wan Y, Gauldie J: Dendritic cells expressing tgfbeta/il-10, and cho cells with ox-2, increase graft survival. Transplant Proc 2001;33:1565-1566.
24. Kluth DC, Ainslie CV, Pearce WP, Finlay S, Clarke D, Anegon I, Rees AJ: Macrophages transfected with adenovirus to express il-4 reduce inflammation in experimental glomerulonephritis. J Immunol 2001;166:4728-4736.
25. Isaka Y, Yamada K, Takabatake Y, Mizui M, Miura-Tsujie M, Ichimaru N, Yazawa K, Utsugi R, Okuyama A, Hori M, Imai E, Takahara S: Electroporation- mediated hgf gene transfection protected the kidney against graft injury. Gene Ther 2005;12:815-820.
26. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ: Inhibition of renal fibrosis by gene transfer of inducible smad7 using ultrasound-microbubble system in rat uuo model. J Am Soc Nephrol 2003;14:1535-1548.
27. Terada Y, Hanada S, Nakao A, Kuwahara M, Sasaki S, Marumo F: Gene transfer of smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. Kidney Int 2002;61:94-98.
28. Takase O, Hirahashi J, Takayanagi A, Chikaraishi A, Marumo T, Ozawa Y, Hayashi M, Shimizu N, Saruta T: Gene transfer of truncated ikappabalpha prevents tubulointerstitial injury. Kidney Int 2003;63:501-513.
29. Yang J, Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002;13:96-107.
30. Herrero-Fresneda I, Torras J, Franquesa M, Vidal A, Cruzado JM, Lloberas N, Fillat C, Grinyo JM: Hgf gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int 2006;70:265-274.